openPR Logo
Press release

Adenoid Cystic Carcinoma Market Size, Share, Trends, and Forecast: 2024-2031 | Amgen, CureVac AG, Elevar Therapeutics.

09-25-2024 02:43 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Adenoid Cystic Carcinoma Market || 2024-2031

Adenoid Cystic Carcinoma Market || 2024-2031

DataM Intelligence has published a new research report on "Adenoid Cystic Carcinoma Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/adenoid-cystic-carcinoma-market

The Adenoid Cystic Carcinoma market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

The Adenoid Cystic Carcinoma (ACC) Market is focused on a rare form of cancer that primarily affects the salivary glands, although it can also occur in other glands and tissues throughout the body. ACC is characterized by slow growth and can be challenging to diagnose, often leading to a delay in treatment. The market for ACC is driven by a need for improved diagnostic tools, effective treatment options, and increasing awareness about this malignancy.

Key Developments:

On June 6, 2022, Ayala Pharmaceuticals, Inc., a clinical-stage oncology company dedicated to developing small molecule therapeutics for patients with rare and aggressive cancers, announced that it would present data from its Phase 2 ACCURACY study at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, which took place from June 3-7, 2022.

Earlier, on February 8, 2021, Elevar Therapeutics, Inc. revealed in a press release that the FDA had granted Orphan Drug Designation to its small molecule tyrosine kinase inhibitor, apatinib (Rivoceranib), for the treatment of the rare disease adenoid cystic carcinoma. This designation highlights the drug's potential in addressing unmet medical needs for patients suffering from this condition.

Forecast Growth Projected:

The Global Adenoid Cystic Carcinoma Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Adenoid Cystic Carcinoma Market:

Amgen, CureVac AG, Elevar Therapeutics, Actuate Therapeutics, Prelude Therapeutics, Merck Sharp &, Dohme Corp., Lilly USA, LLC, Celgene Corporation, and OncoMed Pharmaceuticals.

Segment Covered in the Adenoid Cystic Carcinoma Market:

By Site: Salivary Gland, Lacrimal Gland, Breast, Others.

By Drug Class: Cytotoxic Drugs, Tyrosine Kinase Inhibitors, Monoclonal Antibodies, Others.

By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

The global Adenoid Cystic Carcinoma Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/adenoid-cystic-carcinoma-market

Regional Analysis:

The global Adenoid Cystic Carcinoma Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Adenoid Cystic Carcinoma Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Adenoid Cystic Carcinoma manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Adenoid Cystic Carcinoma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/adenoid-cystic-carcinoma-market

FAQs

How big is the Adenoid Cystic Carcinoma Market?

The Adenoid Cystic Carcinoma Market size was USD 224.3 million in 2023. It is expected to reach USD 344.6 million by 2031.

How fast is the Adenoid Cystic Carcinoma Market growing?

The Adenoid Cystic Carcinoma Market will exhibit a CAGR of 5.6% during the forecast period, 2024-2031.

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adenoid Cystic Carcinoma Market Size, Share, Trends, and Forecast: 2024-2031 | Amgen, CureVac AG, Elevar Therapeutics. here

News-ID: 3667586 • Views:

More Releases from DataM Intelligence 4Market Research

Green Steel Market is expected to reach US$ 140,435.7 million by 2031 | Major Companies - H2 Green Steel, Tata Steel Ltd., ArcelorMittal, Voestalpine.
Green Steel Market is expected to reach US$ 140,435.7 million by 2031 | Major Co …
Market Size and Growth: The Global Green Steel Market size reached US$ 201.3 million in 2022 and is expected to reach US$ 140,435.7 million by 2031, growing with a CAGR of 126.7% during the forecast period 2024-2031. According to DataM Intelligence Report. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/green-steel-market?sz The Green Steel Market refers to the global industry involved in the production, distribution, and adoption of environmentally sustainable steel. It focuses on reducing
Bauxite Market is expected to reach US$ 19.7 billion by 2030 | Top Companies - Rio Tinto, Alcoa Corporation, Guinea Alumina Corporation (GAC).
Bauxite Market is expected to reach US$ 19.7 billion by 2030 | Top Companies - R …
Market Size and Growth: The Global Bauxite Market Size reached US$ 14.8 billion in 2022 and is expected to reach US$ 19.7 billion by 2030, growing with a CAGR of 3.7% during the forecast period 2024-2031. According to DataM Intelligence Report. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/bauxite-market?sz The Bauxite Market refers to the global trade and production of bauxite, the primary ore for aluminum. It encompasses mining, processing, and distribution activities,
Construction Aluminum Market is expected to reach US$1,20,653.41 million by 2032 | Major Companies - Novelis Inc., China Hongqiao Group Limited, Rio Tinto.
Construction Aluminum Market is expected to reach US$1,20,653.41 million by 2032 …
Market Size and Growth: The Global Construction Aluminum Market Size reached US$75,345.01 million in 2024 and is expected to reach US$1,20,653.41 million by 2032, growing at a CAGR of 6.17% during the forecast period 2025-2032. According to DataM Intelligence Report. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/construction-aluminum-market?sz The Construction Aluminum Market refers to the global industry involved in the production, distribution, and use of aluminum materials for construction purposes. It includes aluminum products
Integrated Workplace Management Market 2025-2032 | Latest Developments & Growth Opportunities
Integrated Workplace Management Market 2025-2032 | Latest Developments & Growth …
Market Overview: The Global Integrated Workplace Management Market is estimated to reach at a CAGR of 12.5% within the forecast period (2024-2031). According to DataM Intelligence Report. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/integrated-workplace-management-market?sz The Integrated Workplace Management System (IWMS) Market encompasses software solutions that help organizations efficiently manage real estate, facilities, and workplace resources. It integrates space planning, asset management, maintenance, energy optimization, and workplace analytics, enhancing operational efficiency, cost savings, and

All 5 Releases


More Releases for Adenoid

Adenoid Cystic Carcinoma Pipeline Outlook 2025: Insights Into Therapies, Researc …
DelveInsight's, "Adenoid Cystic Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It covers the Adenoid Cystic Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Adenoid Cystic Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the
Adenoid Cystic Carcinoma Market Outlook, Trends, Challenges and Growth Potential
Adenoid Cystic Carcinoma (ACC) is a rare and slow-growing cancer that typically arises in the salivary glands but can also occur in the breast, trachea, lacrimal glands, and other sites. While it progresses more slowly than many other malignancies, ACC is highly invasive and has a tendency to recur and metastasize even after years of remission. Due to its rarity and complexity, treatment options remain limited, primarily revolving around surgery
Adenoid cystic carcinoma Market Outlook 2034 - Clinical Trials, Market Size, Med …
Adenoid cystic carcinoma companies are OncoC4, Ascentage Pharma, Elevar Therapeutics, CELLESTIA BIOTECH AG, Remix Therapeutics, Rgenta Therapeutics Inc and others. (Albany, USA) DelveInsight's "Adenoid cystic carcinoma Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Adenoid cystic carcinoma, historical and forecasted epidemiology as well as the Adenoid cystic carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Adenoid cystic carcinoma
Adenoid Cystic Carcinoma Market Scope and Competitive Analysis Forecast through …
The Adenoid Cystic Carcinoma Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/adenoid-cystic-carcinoma-market What is the
Revolutionizing Respiratory Health: Unveiling the Latest Breakthroughs in Adenoi …
DelveInsight's, "Adenoid Cystic Carcinoma Pipeline Insight 2023," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Adenoid Cystic Carcinoma pipeline landscape. It covers the Adenoid Cystic Carcinoma pipeline drug profiles, including Adenoid Cystic Carcinoma clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Tonsil and Adenoid Removal Products Market Forecast to 2022
The objective of this report is to describe the market trends and revenue forecasts for tonsil and adenoid removal products market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends. The report